Shoulder Innovations Announces Oversubscribed $42 million Series D Financing
GRAND RAPIDS, Mich., March 6, 2023 -- (Healthcare Sales & Marketing Network) -- Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced closing on an oversubscribed $42 million Series D f... Devices, Orthopaedic, Venture Capital Shoulder Innovations, InSet Stemless Humeral, shoulder arthroplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2023 Category: Pharmaceuticals Source Type: news
Aadi Bioscience Announces Leadership Transition
LOS ANGELES, March 3, 2023 -- (Healthcare Sales & Marketing Network) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway gene... Biopharmaceuticals, Oncology, Personnel Aadi Bioscience, FYARRO, mTOR pathway, PEComa (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 3, 2023 Category: Pharmaceuticals Source Type: news
CD NXT power tool system empowers surgeons through real-time depth measurement
KALAMAZOO, Michigan, USA, March 2, 2023 -- (Healthcare Sales & Marketing Network) -- Stryker (NYSE:SYK) announced the launch of its CD NXT System, the latest innovation in the company's power tools. This patented technology provides real-time depth measur... Devices, Surgery, Product Launch Stryker, CD NXT System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2023 Category: Pharmaceuticals Source Type: news
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian(R) MRI-Guided Radiation Therapy
World's first MRIdian center at Barnes-Jewish Hospital continues to lead the way for advanced precision cancer therapy with MRI-guided radiation
DENVER, March 2, 2023 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (NASDAQ: VRAY) announced t... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2023 Category: Pharmaceuticals Source Type: news
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
Funding to progress Chroma's single-dose epigenetic editing therapies and support expansion of novel genetic medicine platform designed to enable precise gene regulation while preserving genomic integrity
Financing led by GV, with participation from ARC... Biopharmaceuticals, Venture Capital Chroma Medicine, genomic medicine, epigenetic editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2023 Category: Pharmaceuticals Source Type: news
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Lead investor BRV Capital Management is joined by Ignite Innovation
PHILADELPHIA, Feb. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Verismo Therapeutics, a clinical-stage CAR T company, Penn spinout, and pioneer of the novel KIR-CAR platform t... Biopharmaceuticals, Venture Capital Verismo Therapeutics, KIR-CAR, CAR T-cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2023 Category: Pharmaceuticals Source Type: news
Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy
CAMBRIDGE, Mass., Feb. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research collaboration with Vertex Pharmaceuticals I... Biopharmaceuticals Tevard Biosciences, Vertex Pharmaceuticals, Duchenne muscular dystrophy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2023 Category: Pharmaceuticals Source Type: news
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Smith, a seasoned senior healthcare executive, will lead the company's previously announced Phase 2 strategy and execution
Board of Directors thanks Michael Goettler, who will support a smooth transition prior to his departure
PITTSBURGH, Feb. 27, 20... Biopharmaceuticals, Personnel Viatris (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2023 Category: Pharmaceuticals Source Type: news
FDA approves once-weekly efanesoctocog alfa, a new class of high-sustained factor VIII therapy for haemophilia A: Swedish Orphan Biovitrum AB
STOCKHOLM, Feb. 24, 2023 -- (Healthcare Sales & Marketing Network) -- Sobi® today announced that the US Food and Drug Administration (FDA) has approved efanesoctocog alfa [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], a first-... Biopharmaceuticals, FDA Swedish Orphan Biovitrum, efanesoctocog alfa, factor VIII, haemophilia A (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 24, 2023 Category: Pharmaceuticals Source Type: news
Transmural Systems Electrosurgical Guidewire System (TELLTALE) Used in First Procedure in United States in IDE Pivotal Study
ANDOVER, Mass., Feb. 23, 2023 -- (Healthcare Sales & Marketing Network) -- Transmural Systems the leader in transcatheter electrosurgery for structural interventions announced today successful first-in-human procedure with its TELLTALE electrosurgical gui... Devices, Interventional, Cardiology Transmural Systems, transcatheter electrosurgery, TELLTALE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2023 Category: Pharmaceuticals Source Type: news
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Partnership Combines AbbVie's extensive capabilities with Capsida's novel adeno-associated virus (AAV) engineering platform
Builds upon the neurodegenerative disease partnership announced in 2021
NORTH CHICAGO, Ill. and THOUSAND OAKS, Calif., Feb. 23... Biopharmaceuticals, Ophthalmology AbbVie, Capsida Biotherapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2023 Category: Pharmaceuticals Source Type: news
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Funding enables completion of ongoing Phase 1/2 study of bispecific antibody HMB-001 in Glanzmann Thrombasthenia, initiation of pivotal studies, start and conclusion of Phase 1/2 study of HMB-VWF in von Willebrand Disease, as well as future pipeline evolut... Biopharmaceuticals, Venture Capital Hemab Therapeutics, Glanzmann Thrombasthenia, von Willebrand Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 21, 2023 Category: Pharmaceuticals Source Type: news
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature
DUBLIN, Feb. 17, 2023 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the Aurora E... Devices, Cardiology, Regulatory Medtronic, Aurora EV-ICD, Epsila EV, MRI SureScan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 17, 2023 Category: Pharmaceuticals Source Type: news
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
SUNNYVALE, Calif., Feb. 16, 2023 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative Evidence) indicates that ste... Devices, Oncology Accuray, CyberKnife, stereotactic body radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2023 Category: Pharmaceuticals Source Type: news
Zephyrus Innovations announces US FDA approval for its Aeroject(TM) 3ml safety syringe
Aeroject™ 3ml safety syringe is a single-use, affordable, first generation syringe
Aeroject™ has a permanently attached needle system, which upon retraction, fully encases the needle, preventing needle reuse and accidental needlestick
The ultra-low w... Devices, FDA Zephyrus Innovations, Aeroject, safety syringe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2023 Category: Pharmaceuticals Source Type: news
